Hikma Pharmaceuticals Aktie
17,60
EUR
-0,70
EUR
-3,83
%
16,83
CHF
-0,08
CHF
-0,46
%
Werbung
Hikma Pharmaceuticals Aktie Analyse
| 14.12.12 | Hikma Pharmaceuticals overweight | Morgan Stanley | |
| 15.10.12 | Hikma Pharmaceuticals overweight | J.P. Morgan Cazenove | |
| 10.10.11 | Hikma Pharmaceuticals buy | Citigroup Corp. | |
| 21.07.09 | Hikma Pharmaceuticals | Global Biotech Investing |
Werbung
Werbung